Amarin Corp. plc, of Dublin, Ireland, submitted a supplemental new drug application (sNDA) to the FDA seeking approval for Chemport Inc. as an additional active pharmaceutical ingredient supplier for Vascepa (icosapent ethyl).
To continue reading subscribe now to BioWorld Asia (formerly International)
Learn More about BioWorld Asia (formerly International)
Already a subscriber? Sign In or Buy now to activate your subscription